Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to -$0.62.

  • Biofrontera's EPS (Basic) rose 3673.47% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 33281.25%. This contributed to the annual value of -$3.22 for FY2024, which is 7527.38% up from last year.
  • As of Q3 2025, Biofrontera's EPS (Basic) stood at -$0.62, which was up 3673.47% from -$0.57 recorded in Q2 2025.
  • Biofrontera's 5-year EPS (Basic) high stood at $4.55 for Q4 2023, and its period low was -$7.23 during Q2 2023.
  • Over the past 5 years, Biofrontera's median EPS (Basic) value was -$0.9 (recorded in 2022), while the average stood at -$1.51.
  • Data for Biofrontera's EPS (Basic) shows a peak YoY increase of 26250.0% (in 2023) and a maximum YoY decrease of 179748.73% (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows Biofrontera's EPS (Basic) stood at -$1.38 in 2021, then crashed by 102.9% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then plummeted by 105.56% to -$0.25 in 2024, then crashed by 144.99% to -$0.62 in 2025.
  • Its last three reported values are -$0.62 in Q3 2025, -$0.57 for Q2 2025, and -$0.47 during Q1 2025.